Alla Smolgovsky

Papers

Total Citations

H-Index

About

Alla Smolgovsky is a molecular biologist and clinical genomics researcher whose work has been pivotal in advancing the real-time genomic surveillance of SARS-CoV-2. Her primary research focuses on the development and validation of high-throughput sequencing workflows for viral pathogens, with a particular emphasis on translating cutting-edge next-generation sequencing (NGS) technologies into practical clinical laboratory applications. Smolgovsky’s most cited paper, “Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory” (2022, 26 citations), stands as a landmark contribution to pandemic response. In this work, she designed a robust, scalable method for whole genome sequencing that enables rapid monitoring of emerging mutations—critical for identifying new diagnostic and therapeutic targets. By streamlining complex NGS protocols for clinical use, her research has empowered laboratories worldwide to track viral evolution in real time, directly informing COVID-19 control strategies. This achievement not only demonstrates her technical expertise in genomics but also highlights her commitment to bridging the gap between advanced molecular tools and public health needs. Smolgovsky’s work continues to shape how clinical labs prepare for future infectious disease outbreaks.